文献速递妇科

术前宫颈锥切对宫颈癌患者子宫切除术后生存与复发影响的系统评价与Meta分析

Effect of preoperative cervical conization before hysterectomy on survival and recurrence of patients with cervical cancer: A systematic review and meta-analysis.
PubMed 文献 · Gynecol Oncol · 2023-05-17

该系统评价与Meta分析纳入11项研究共4184例患者,比较术前接受与未接受宫颈锥切的宫颈癌患者行子宫切除术的临床结局。结果显示术前锥切组无病生存期和总生存期改善、复发风险降低,术中及术后不良事件无显著统计学差异。亚组分析中,接受微创手术、局部肿瘤较小及无淋巴结受累的患者从术前锥切中获益更多。

要点

  • 术前锥切组较未锥切组无病生存期改善(HR 0.23,95%CI 0.12-0.44)。
  • 术前锥切组较未锥切组总生存期改善(HR 0.54,95%CI 0.33-0.86)。
  • 术前锥切组复发风险低于未锥切组(OR 0.29,95%CI 0.17-0.48)。

核心结论

  • 根治性子宫切除术前宫颈锥切可能对早期宫颈癌治疗具有保护作用,生存更好且复发更少,尤其在早期及接受微创手术的患者中。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase、Cochrane CENTRAL、ICTRP及ClinicalTrials.gov从建库至2022年5月1日发表的文献,纳入11项研究共4184例参与者。
  • 术前锥切组2122例,非锥切组2062例。

主要发现

  • 无病生存期(DFS):术前锥切组较非锥切组改善(HR 0.23;95%CI 0.12-0.44;1616例参与者;P=0.030)。
  • 总生存期(OS):术前锥切组较非锥切组改善(HR 0.54;95%CI 0.33-0.86;1835例参与者;P=0.597)。
  • 复发风险:术前锥切组低于非锥切组(OR 0.29;95%CI 0.17-0.48;1099例参与者;P=0.434)。
  • 术中不良事件:术前锥切组与非锥切组无显著统计学差异(OR 0.81;95%CI 0.18-3.70;530例参与者;P=0.555)。
  • 术后不良事件:术前锥切组与非锥切组无显著统计学差异(OR 1.24;95%CI 0.54-2.85;530例参与者;P=0.170)。

关键数值与推荐

  • 亚组分析中从术前锥切获益更多的患者为:接受微创手术、局部肿瘤病灶较小及无淋巴结受累者。

临床怎么用

  • 原文结论认为根治性子宫切除术前宫颈锥切可能对早期宫颈癌治疗具有保护作用,生存更好且复发更少,尤其在早期及接受微创手术的患者中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Conization plays a therapeutic and diagnostic role in cervical cancer. We conducted a systematic review and meta-analysis to compare the clinical outcomes of patients with cervical cancer who underwent hysterectomy with versus without preoperative cervical conization. METHODS: In this meta-analysis, we analyzed studies published in PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), International Clinical Trials Registry Platform (ICTRP), and Clinical Trials. gov that appeared in our search from inception to May 1, 2022. RESULTS: Eleven studies with 4184 participants were included in this review. There were 2122 patients in the preoperative conization group and 2062 patients in the non-conization group. The meta-analysis showed that disease free survival (DFS) (hazard ratio [HR]: 0.23; 95% CI: 0.12-0.44; 1616 participants; P = 0.030) and overall survival (OS) (HR: 0.54; 95% CI: 0.33-0.86; 1835 participants; P = 0.597) were improved in the preoperative conization group compared with those in the non-conization group. The risk for recurrence was lower in the preoperative conization group than in the non-conization group (odds ratio [OR]: 0.29; 95% CI: 0.17-0.48; 1099 participants; P = 0.434). There was no significant statistical difference regarding intraoperative adverse events (OR: 0.81; 95% CI: 0.18-3.70; 530 participants; P = 0.555) and postoperative adverse events (OR: 1.24; 95% CI: 0.54-2.85; 530 participants; P = 0.170) between the preoperative conization group and non-conization group. In subgroup analysis, patients who benefited more from preoperative conization, had underwent minimally invasive surgery, had smaller local tumor lesions, and had no lymph node involvement. CONCLUSIONS: Preoperative conization before radical hysterectomy may have a protective effect in the treatment of early cervical cancer, with better survival and less recurrence, especially when the patient is at an early stage and undergoes minimally invasive surgery.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Han L, Chen Y, Zheng A, et al. Effect of preoperative cervical conization before hysterectomy on survival and recurrence of patients with cervical cancer: A systematic review and meta-analysis. Gynecol Oncol. 2023. PMID: 37207501. doi:10.1016/j.ygyno.2023.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。